nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—ADRA2A—epilepsy syndrome	0.179	0.347	CbGaD
Yohimbine—SLC6A4—epilepsy syndrome	0.136	0.264	CbGaD
Yohimbine—HTR2A—epilepsy syndrome	0.105	0.203	CbGaD
Yohimbine—CYP2D6—epilepsy syndrome	0.0958	0.186	CbGaD
Yohimbine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0175	0.0819	CbGbCtD
Yohimbine—CYP3A4—Felbamate—epilepsy syndrome	0.0163	0.0762	CbGbCtD
Yohimbine—CYP3A4—Trimethadione—epilepsy syndrome	0.0163	0.0762	CbGbCtD
Yohimbine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0153	0.0716	CbGbCtD
Yohimbine—CYP2D6—Propofol—epilepsy syndrome	0.0145	0.0677	CbGbCtD
Yohimbine—CYP3A4—Clonazepam—epilepsy syndrome	0.0138	0.0648	CbGbCtD
Yohimbine—CYP3A4—Clobazam—epilepsy syndrome	0.0133	0.0621	CbGbCtD
Yohimbine—CYP3A4—Rufinamide—epilepsy syndrome	0.0113	0.0528	CbGbCtD
Yohimbine—CYP3A4—Carbamazepine—epilepsy syndrome	0.011	0.0514	CbGbCtD
Yohimbine—CYP3A4—Primidone—epilepsy syndrome	0.0103	0.048	CbGbCtD
Yohimbine—CYP3A4—Phenytoin—epilepsy syndrome	0.00985	0.0461	CbGbCtD
Yohimbine—HTR1D—meninx—epilepsy syndrome	0.0098	0.0988	CbGeAlD
Yohimbine—CYP3A4—Propofol—epilepsy syndrome	0.00919	0.043	CbGbCtD
Yohimbine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00878	0.0411	CbGbCtD
Yohimbine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00878	0.0411	CbGbCtD
Yohimbine—CYP3A4—Midazolam—epilepsy syndrome	0.00866	0.0406	CbGbCtD
Yohimbine—CYP3A4—Diazepam—epilepsy syndrome	0.00833	0.039	CbGbCtD
Yohimbine—CYP3A4—Zonisamide—epilepsy syndrome	0.00813	0.0381	CbGbCtD
Yohimbine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00656	0.0307	CbGbCtD
Yohimbine—CYP3A4—Topiramate—epilepsy syndrome	0.00592	0.0277	CbGbCtD
Yohimbine—HTR2A—phrenic nerve—epilepsy syndrome	0.00527	0.0531	CbGeAlD
Yohimbine—DRD3—telencephalic ventricle—epilepsy syndrome	0.004	0.0403	CbGeAlD
Yohimbine—HTR1F—ganglion—epilepsy syndrome	0.00353	0.0355	CbGeAlD
Yohimbine—HTR2A—locus ceruleus—epilepsy syndrome	0.00235	0.0237	CbGeAlD
Yohimbine—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00232	0.0234	CbGeAlD
Yohimbine—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00225	0.0226	CbGeAlD
Yohimbine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00222	0.0224	CbGeAlD
Yohimbine—HTR2A—cerebellar cortex—epilepsy syndrome	0.00192	0.0193	CbGeAlD
Yohimbine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00187	0.0189	CbGeAlD
Yohimbine—HTR2A—vagus nerve—epilepsy syndrome	0.0018	0.0182	CbGeAlD
Yohimbine—DRD2—telencephalic ventricle—epilepsy syndrome	0.00169	0.0171	CbGeAlD
Yohimbine—HTR1F—forebrain—epilepsy syndrome	0.00148	0.0149	CbGeAlD
Yohimbine—HTR1B—ganglion—epilepsy syndrome	0.00144	0.0146	CbGeAlD
Yohimbine—HTR1D—ganglion—epilepsy syndrome	0.0014	0.0141	CbGeAlD
Yohimbine—HTR2C—ganglion—epilepsy syndrome	0.00138	0.014	CbGeAlD
Yohimbine—HTR1F—telencephalon—epilepsy syndrome	0.00136	0.0137	CbGeAlD
Yohimbine—HTR2A—pons—epilepsy syndrome	0.00136	0.0137	CbGeAlD
Yohimbine—SLC6A4—ganglion—epilepsy syndrome	0.00131	0.0132	CbGeAlD
Yohimbine—HTR2A—autonomic nervous system—epilepsy syndrome	0.00125	0.0126	CbGeAlD
Yohimbine—HTR1A—ganglion—epilepsy syndrome	0.00117	0.0117	CbGeAlD
Yohimbine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00112	0.0112	CbGeAlD
Yohimbine—DRD2—ganglion—epilepsy syndrome	0.00105	0.0106	CbGeAlD
Yohimbine—SLC6A4—hindbrain—epilepsy syndrome	0.000996	0.01	CbGeAlD
Yohimbine—Reserpine—ABCC2—epilepsy syndrome	0.000981	0.731	CrCbGaD
Yohimbine—HTR1A—hindbrain—epilepsy syndrome	0.000884	0.00891	CbGeAlD
Yohimbine—HTR1F—head—epilepsy syndrome	0.000847	0.00854	CbGeAlD
Yohimbine—HTR1F—nervous system—epilepsy syndrome	0.000803	0.00809	CbGeAlD
Yohimbine—DRD2—hindbrain—epilepsy syndrome	0.000799	0.00805	CbGeAlD
Yohimbine—ADRA1D—forebrain—epilepsy syndrome	0.000785	0.00791	CbGeAlD
Yohimbine—HTR1F—central nervous system—epilepsy syndrome	0.000773	0.00779	CbGeAlD
Yohimbine—ADRA1D—telencephalon—epilepsy syndrome	0.000722	0.00727	CbGeAlD
Yohimbine—HTR2A—ganglion—epilepsy syndrome	0.000695	0.007	CbGeAlD
Yohimbine—HTR1B—brainstem—epilepsy syndrome	0.000628	0.00633	CbGeAlD
Yohimbine—HTR1F—brain—epilepsy syndrome	0.000614	0.00619	CbGeAlD
Yohimbine—HTR1D—brainstem—epilepsy syndrome	0.000608	0.00613	CbGeAlD
Yohimbine—HTR1B—forebrain—epilepsy syndrome	0.000606	0.00611	CbGeAlD
Yohimbine—HTR2C—brainstem—epilepsy syndrome	0.000602	0.00607	CbGeAlD
Yohimbine—DRD3—head—epilepsy syndrome	0.000598	0.00603	CbGeAlD
Yohimbine—HTR1D—forebrain—epilepsy syndrome	0.000587	0.00591	CbGeAlD
Yohimbine—HTR2C—forebrain—epilepsy syndrome	0.000581	0.00586	CbGeAlD
Yohimbine—SLC6A4—brainstem—epilepsy syndrome	0.000571	0.00575	CbGeAlD
Yohimbine—DRD3—nervous system—epilepsy syndrome	0.000567	0.00571	CbGeAlD
Yohimbine—HTR1B—telencephalon—epilepsy syndrome	0.000557	0.00562	CbGeAlD
Yohimbine—SLC6A4—forebrain—epilepsy syndrome	0.000551	0.00555	CbGeAlD
Yohimbine—DRD3—central nervous system—epilepsy syndrome	0.000546	0.0055	CbGeAlD
Yohimbine—HTR2B—forebrain—epilepsy syndrome	0.000546	0.0055	CbGeAlD
Yohimbine—HTR1D—telencephalon—epilepsy syndrome	0.00054	0.00544	CbGeAlD
Yohimbine—HTR2C—telencephalon—epilepsy syndrome	0.000534	0.00538	CbGeAlD
Yohimbine—HTR2A—hindbrain—epilepsy syndrome	0.000527	0.00531	CbGeAlD
Yohimbine—HTR1A—brainstem—epilepsy syndrome	0.000507	0.00511	CbGeAlD
Yohimbine—SLC6A4—telencephalon—epilepsy syndrome	0.000506	0.0051	CbGeAlD
Yohimbine—HTR2B—telencephalon—epilepsy syndrome	0.000502	0.00506	CbGeAlD
Yohimbine—HTR1A—forebrain—epilepsy syndrome	0.000489	0.00493	CbGeAlD
Yohimbine—CYP2D6—hindbrain—epilepsy syndrome	0.00048	0.00484	CbGeAlD
Yohimbine—ADRA1B—head—epilepsy syndrome	0.000459	0.00463	CbGeAlD
Yohimbine—DRD2—brainstem—epilepsy syndrome	0.000458	0.00461	CbGeAlD
Yohimbine—HTR1A—telencephalon—epilepsy syndrome	0.00045	0.00453	CbGeAlD
Yohimbine—ADRA1D—head—epilepsy syndrome	0.000449	0.00453	CbGeAlD
Yohimbine—DRD2—forebrain—epilepsy syndrome	0.000442	0.00445	CbGeAlD
Yohimbine—ADRA1B—nervous system—epilepsy syndrome	0.000436	0.00439	CbGeAlD
Yohimbine—DRD3—brain—epilepsy syndrome	0.000433	0.00437	CbGeAlD
Yohimbine—ADRA1D—nervous system—epilepsy syndrome	0.000426	0.00429	CbGeAlD
Yohimbine—HTR2C—medulla oblongata—epilepsy syndrome	0.00042	0.00423	CbGeAlD
Yohimbine—ADRA1B—central nervous system—epilepsy syndrome	0.000419	0.00423	CbGeAlD
Yohimbine—ADRA1D—central nervous system—epilepsy syndrome	0.00041	0.00413	CbGeAlD
Yohimbine—DRD2—telencephalon—epilepsy syndrome	0.000406	0.0041	CbGeAlD
Yohimbine—HTR1B—midbrain—epilepsy syndrome	0.0004	0.00403	CbGeAlD
Yohimbine—ADRA2C—telencephalon—epilepsy syndrome	0.000395	0.00398	CbGeAlD
Yohimbine—HTR1B—spinal cord—epilepsy syndrome	0.00039	0.00394	CbGeAlD
Yohimbine—HTR1D—midbrain—epilepsy syndrome	0.000387	0.0039	CbGeAlD
Yohimbine—HTR2C—midbrain—epilepsy syndrome	0.000384	0.00387	CbGeAlD
Yohimbine—HTR2C—spinal cord—epilepsy syndrome	0.000374	0.00377	CbGeAlD
Yohimbine—SLC6A4—midbrain—epilepsy syndrome	0.000364	0.00367	CbGeAlD
Yohimbine—Reserpine—ABCB1—epilepsy syndrome	0.000361	0.269	CrCbGaD
Yohimbine—SLC6A4—spinal cord—epilepsy syndrome	0.000355	0.00358	CbGeAlD
Yohimbine—HTR1B—head—epilepsy syndrome	0.000347	0.0035	CbGeAlD
Yohimbine—ADRA2A—forebrain—epilepsy syndrome	0.000343	0.00345	CbGeAlD
Yohimbine—HTR1D—head—epilepsy syndrome	0.000336	0.00339	CbGeAlD
Yohimbine—ADRA1B—brain—epilepsy syndrome	0.000333	0.00336	CbGeAlD
Yohimbine—HTR2C—head—epilepsy syndrome	0.000333	0.00335	CbGeAlD
Yohimbine—HTR1B—nervous system—epilepsy syndrome	0.000329	0.00332	CbGeAlD
Yohimbine—ADRA1D—brain—epilepsy syndrome	0.000326	0.00328	CbGeAlD
Yohimbine—HTR1A—midbrain—epilepsy syndrome	0.000323	0.00325	CbGeAlD
Yohimbine—HTR1D—nervous system—epilepsy syndrome	0.000319	0.00321	CbGeAlD
Yohimbine—HTR1B—central nervous system—epilepsy syndrome	0.000317	0.00319	CbGeAlD
Yohimbine—HTR2C—nervous system—epilepsy syndrome	0.000315	0.00318	CbGeAlD
Yohimbine—SLC6A4—head—epilepsy syndrome	0.000315	0.00318	CbGeAlD
Yohimbine—ADRA2A—telencephalon—epilepsy syndrome	0.000315	0.00318	CbGeAlD
Yohimbine—HTR1A—spinal cord—epilepsy syndrome	0.000315	0.00318	CbGeAlD
Yohimbine—HTR2B—head—epilepsy syndrome	0.000313	0.00315	CbGeAlD
Yohimbine—ADRA2C—medulla oblongata—epilepsy syndrome	0.00031	0.00313	CbGeAlD
Yohimbine—HTR1D—central nervous system—epilepsy syndrome	0.000307	0.00309	CbGeAlD
Yohimbine—HTR2C—central nervous system—epilepsy syndrome	0.000304	0.00306	CbGeAlD
Yohimbine—HTR2A—brainstem—epilepsy syndrome	0.000302	0.00304	CbGeAlD
Yohimbine—SLC6A4—nervous system—epilepsy syndrome	0.000299	0.00301	CbGeAlD
Yohimbine—HTR2B—nervous system—epilepsy syndrome	0.000296	0.00299	CbGeAlD
Yohimbine—DRD2—midbrain—epilepsy syndrome	0.000292	0.00294	CbGeAlD
Yohimbine—HTR2A—forebrain—epilepsy syndrome	0.000291	0.00294	CbGeAlD
Yohimbine—SLC6A4—central nervous system—epilepsy syndrome	0.000288	0.0029	CbGeAlD
Yohimbine—HTR2B—central nervous system—epilepsy syndrome	0.000285	0.00288	CbGeAlD
Yohimbine—ADRA2C—midbrain—epilepsy syndrome	0.000284	0.00286	CbGeAlD
Yohimbine—HTR1A—head—epilepsy syndrome	0.00028	0.00282	CbGeAlD
Yohimbine—ADRA2C—spinal cord—epilepsy syndrome	0.000277	0.00279	CbGeAlD
Yohimbine—CYP2D6—brainstem—epilepsy syndrome	0.000275	0.00277	CbGeAlD
Yohimbine—HTR2A—telencephalon—epilepsy syndrome	0.000268	0.0027	CbGeAlD
Yohimbine—CYP2D6—forebrain—epilepsy syndrome	0.000266	0.00268	CbGeAlD
Yohimbine—HTR1A—nervous system—epilepsy syndrome	0.000265	0.00268	CbGeAlD
Yohimbine—HTR1A—central nervous system—epilepsy syndrome	0.000256	0.00258	CbGeAlD
Yohimbine—DRD2—head—epilepsy syndrome	0.000253	0.00255	CbGeAlD
Yohimbine—HTR1B—brain—epilepsy syndrome	0.000251	0.00253	CbGeAlD
Yohimbine—HTR1A—cerebellum—epilepsy syndrome	0.00025	0.00252	CbGeAlD
Yohimbine—ADRA2A—medulla oblongata—epilepsy syndrome	0.000248	0.0025	CbGeAlD
Yohimbine—ADRA2C—head—epilepsy syndrome	0.000246	0.00248	CbGeAlD
Yohimbine—CYP2D6—telencephalon—epilepsy syndrome	0.000244	0.00246	CbGeAlD
Yohimbine—HTR1D—brain—epilepsy syndrome	0.000243	0.00245	CbGeAlD
Yohimbine—HTR2C—brain—epilepsy syndrome	0.000241	0.00243	CbGeAlD
Yohimbine—DRD2—nervous system—epilepsy syndrome	0.00024	0.00242	CbGeAlD
Yohimbine—ADRA2C—nervous system—epilepsy syndrome	0.000233	0.00235	CbGeAlD
Yohimbine—DRD2—central nervous system—epilepsy syndrome	0.000231	0.00233	CbGeAlD
Yohimbine—SLC6A4—brain—epilepsy syndrome	0.000229	0.0023	CbGeAlD
Yohimbine—HTR2B—brain—epilepsy syndrome	0.000226	0.00228	CbGeAlD
Yohimbine—ADRA2A—midbrain—epilepsy syndrome	0.000226	0.00228	CbGeAlD
Yohimbine—DRD2—cerebellum—epilepsy syndrome	0.000226	0.00228	CbGeAlD
Yohimbine—ADRA2C—central nervous system—epilepsy syndrome	0.000225	0.00226	CbGeAlD
Yohimbine—ADRA2A—spinal cord—epilepsy syndrome	0.000221	0.00223	CbGeAlD
Yohimbine—ADRA2C—cerebellum—epilepsy syndrome	0.000219	0.00221	CbGeAlD
Yohimbine—HTR2A—medulla oblongata—epilepsy syndrome	0.000211	0.00212	CbGeAlD
Yohimbine—HTR1A—brain—epilepsy syndrome	0.000203	0.00205	CbGeAlD
Yohimbine—ADRA2A—head—epilepsy syndrome	0.000196	0.00198	CbGeAlD
Yohimbine—HTR2A—midbrain—epilepsy syndrome	0.000192	0.00194	CbGeAlD
Yohimbine—HTR2A—spinal cord—epilepsy syndrome	0.000188	0.00189	CbGeAlD
Yohimbine—ADRA2A—nervous system—epilepsy syndrome	0.000186	0.00188	CbGeAlD
Yohimbine—DRD2—brain—epilepsy syndrome	0.000183	0.00185	CbGeAlD
Yohimbine—ADRA2A—central nervous system—epilepsy syndrome	0.000179	0.00181	CbGeAlD
Yohimbine—ADRA2C—brain—epilepsy syndrome	0.000178	0.0018	CbGeAlD
Yohimbine—ADRA2A—cerebellum—epilepsy syndrome	0.000175	0.00176	CbGeAlD
Yohimbine—HTR2A—head—epilepsy syndrome	0.000167	0.00168	CbGeAlD
Yohimbine—HTR2A—nervous system—epilepsy syndrome	0.000158	0.00159	CbGeAlD
Yohimbine—HTR2A—central nervous system—epilepsy syndrome	0.000152	0.00154	CbGeAlD
Yohimbine—CYP2D6—head—epilepsy syndrome	0.000152	0.00153	CbGeAlD
Yohimbine—HTR2A—cerebellum—epilepsy syndrome	0.000149	0.0015	CbGeAlD
Yohimbine—CYP3A4—nervous system—epilepsy syndrome	0.000146	0.00148	CbGeAlD
Yohimbine—CYP2D6—nervous system—epilepsy syndrome	0.000144	0.00145	CbGeAlD
Yohimbine—ADRA2A—brain—epilepsy syndrome	0.000142	0.00143	CbGeAlD
Yohimbine—CYP3A4—central nervous system—epilepsy syndrome	0.000141	0.00142	CbGeAlD
Yohimbine—CYP2D6—central nervous system—epilepsy syndrome	0.000139	0.0014	CbGeAlD
Yohimbine—CYP2D6—cerebellum—epilepsy syndrome	0.000136	0.00137	CbGeAlD
Yohimbine—HTR2A—brain—epilepsy syndrome	0.000121	0.00122	CbGeAlD
Yohimbine—CYP2D6—brain—epilepsy syndrome	0.00011	0.00111	CbGeAlD
Yohimbine—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	2.85e-06	1.67e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	2.85e-06	1.67e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	2.84e-06	1.67e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	2.84e-06	1.67e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	2.84e-06	1.66e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	2.84e-06	1.66e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	2.83e-06	1.66e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.83e-06	1.66e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	2.82e-06	1.65e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	2.81e-06	1.65e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CCL2—epilepsy syndrome	2.81e-06	1.65e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	2.81e-06	1.65e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	2.8e-06	1.64e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.8e-06	1.64e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—AGT—epilepsy syndrome	2.8e-06	1.64e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—TH—epilepsy syndrome	2.79e-06	1.64e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	2.78e-06	1.63e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	2.77e-06	1.62e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	2.76e-06	1.62e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	2.75e-06	1.62e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	2.75e-06	1.61e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.75e-06	1.61e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—APOE—epilepsy syndrome	2.74e-06	1.61e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.74e-06	1.61e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	2.73e-06	1.6e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	2.73e-06	1.6e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	2.72e-06	1.6e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	2.72e-06	1.6e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	2.72e-06	1.59e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	2.71e-06	1.59e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	2.71e-06	1.59e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	2.7e-06	1.58e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	2.7e-06	1.58e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	2.66e-06	1.56e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	2.65e-06	1.55e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	2.65e-06	1.55e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—ALB—epilepsy syndrome	2.64e-06	1.55e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.62e-06	1.54e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	2.62e-06	1.54e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	2.61e-06	1.53e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	2.61e-06	1.53e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	2.61e-06	1.53e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	2.59e-06	1.52e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	2.59e-06	1.52e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	2.57e-06	1.51e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	2.57e-06	1.51e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	2.56e-06	1.5e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	2.54e-06	1.49e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	2.54e-06	1.49e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	2.54e-06	1.49e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	2.53e-06	1.49e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	2.52e-06	1.48e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	2.52e-06	1.48e-05	CbGpPWpGaD
Yohimbine—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	2.51e-06	1.47e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	2.51e-06	1.47e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	2.5e-06	1.47e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	2.49e-06	1.46e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	2.48e-06	1.46e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	2.48e-06	1.46e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	2.47e-06	1.45e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	2.46e-06	1.45e-05	CbGpPWpGaD
Yohimbine—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.46e-06	1.44e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	2.45e-06	1.44e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	2.44e-06	1.43e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	2.43e-06	1.43e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	2.42e-06	1.42e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	2.41e-06	1.42e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	2.41e-06	1.42e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	2.4e-06	1.41e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	2.38e-06	1.4e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.37e-06	1.39e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	2.37e-06	1.39e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.36e-06	1.39e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	2.36e-06	1.39e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—RELA—epilepsy syndrome	2.36e-06	1.38e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	2.36e-06	1.38e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—POMC—epilepsy syndrome	2.35e-06	1.38e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	2.35e-06	1.38e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.34e-06	1.37e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	2.34e-06	1.37e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	2.34e-06	1.37e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	2.33e-06	1.37e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.33e-06	1.37e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	2.33e-06	1.36e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	2.31e-06	1.36e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	2.31e-06	1.36e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	2.31e-06	1.36e-05	CbGpPWpGaD
Yohimbine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.31e-06	1.35e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	2.3e-06	1.35e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.3e-06	1.35e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	2.29e-06	1.35e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	2.29e-06	1.34e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	2.29e-06	1.34e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.28e-06	1.34e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	2.28e-06	1.34e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.27e-06	1.33e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	2.24e-06	1.32e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.23e-06	1.31e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	2.23e-06	1.31e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	2.22e-06	1.3e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	2.21e-06	1.3e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	2.2e-06	1.29e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	2.2e-06	1.29e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	2.16e-06	1.27e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	2.16e-06	1.27e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.16e-06	1.27e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	2.16e-06	1.27e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.15e-06	1.26e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	2.15e-06	1.26e-05	CbGpPWpGaD
Yohimbine—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.15e-06	1.26e-05	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	2.15e-06	1.26e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—ALB—epilepsy syndrome	2.15e-06	1.26e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	2.14e-06	1.26e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	2.13e-06	1.25e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	2.13e-06	1.25e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	2.13e-06	1.25e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	2.12e-06	1.24e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	2.12e-06	1.24e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	2.11e-06	1.24e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	2.11e-06	1.24e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	2.1e-06	1.23e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	2.09e-06	1.23e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	2.09e-06	1.22e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.08e-06	1.22e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	2.07e-06	1.21e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—JUN—epilepsy syndrome	2.07e-06	1.21e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.06e-06	1.21e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	2.05e-06	1.21e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.05e-06	1.2e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	2.04e-06	1.2e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	2.02e-06	1.18e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	2.01e-06	1.18e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	2.01e-06	1.18e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	2e-06	1.18e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	1.99e-06	1.17e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	1.99e-06	1.17e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.97e-06	1.15e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.96e-06	1.15e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	1.95e-06	1.14e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.95e-06	1.14e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	1.95e-06	1.14e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.95e-06	1.14e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	1.94e-06	1.14e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.94e-06	1.14e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.94e-06	1.14e-05	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.94e-06	1.14e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.93e-06	1.13e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	1.92e-06	1.13e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	1.92e-06	1.13e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	1.91e-06	1.12e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.88e-06	1.1e-05	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.87e-06	1.1e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	1.86e-06	1.09e-05	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.86e-06	1.09e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.85e-06	1.09e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—SRC—epilepsy syndrome	1.85e-06	1.09e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	1.85e-06	1.09e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.85e-06	1.09e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	1.84e-06	1.08e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.83e-06	1.07e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.82e-06	1.07e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.82e-06	1.07e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	1.81e-06	1.06e-05	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.81e-06	1.06e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	1.8e-06	1.06e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.8e-06	1.06e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.8e-06	1.06e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.8e-06	1.06e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	1.79e-06	1.05e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	1.79e-06	1.05e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.78e-06	1.05e-05	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.78e-06	1.05e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	1.78e-06	1.04e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.77e-06	1.04e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	1.77e-06	1.04e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.76e-06	1.03e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.75e-06	1.03e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	1.74e-06	1.02e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	1.74e-06	1.02e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	1.74e-06	1.02e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.74e-06	1.02e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	1.71e-06	1.01e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.7e-06	9.97e-06	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	1.69e-06	9.94e-06	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.69e-06	9.91e-06	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	1.67e-06	9.81e-06	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	1.67e-06	9.78e-06	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.64e-06	9.64e-06	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.64e-06	9.63e-06	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.63e-06	9.56e-06	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.63e-06	9.55e-06	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.62e-06	9.49e-06	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.62e-06	9.48e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	1.62e-06	9.47e-06	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.61e-06	9.47e-06	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	1.61e-06	9.42e-06	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	1.6e-06	9.39e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.58e-06	9.29e-06	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.58e-06	9.27e-06	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.57e-06	9.23e-06	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.56e-06	9.18e-06	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	1.56e-06	9.17e-06	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	1.56e-06	9.12e-06	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	1.54e-06	9.02e-06	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.54e-06	9.02e-06	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.53e-06	8.99e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.52e-06	8.93e-06	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.52e-06	8.93e-06	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-06	8.88e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.5e-06	8.81e-06	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.5e-06	8.79e-06	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.49e-06	8.75e-06	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.47e-06	8.62e-06	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.47e-06	8.61e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.46e-06	8.57e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.46e-06	8.55e-06	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.42e-06	8.32e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.41e-06	8.3e-06	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.4e-06	8.2e-06	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.4e-06	8.18e-06	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.38e-06	8.1e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.38e-06	8.08e-06	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-06	7.97e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.36e-06	7.97e-06	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	1.35e-06	7.89e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.34e-06	7.83e-06	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	1.32e-06	7.73e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	1.27e-06	7.45e-06	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	1.24e-06	7.26e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.24e-06	7.25e-06	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.22e-06	7.17e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.19e-06	6.99e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.17e-06	6.85e-06	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	1.16e-06	6.81e-06	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	1.15e-06	6.75e-06	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	1.15e-06	6.75e-06	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.04e-06	6.1e-06	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1e-06	5.89e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1e-06	5.88e-06	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	9.98e-07	5.86e-06	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	9.71e-07	5.7e-06	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	9.56e-07	5.61e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	9.43e-07	5.53e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.14e-07	5.36e-06	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	8.81e-07	5.17e-06	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	8.67e-07	5.09e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8e-07	4.69e-06	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	7.89e-07	4.63e-06	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.15e-07	3.61e-06	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.02e-07	2.36e-06	CbGpPWpGaD
